meg terrell joins us where we stand, terrell, meg. >> hi, brian as we are doing the social distancing and working from home to try to flatten the curb, rbc's team led by canon mckay did some modeling looking at what we can learn from china, italy and other places and we've gotten some of the graphs re-created here for you so the red line here are the total cases in china and the blue line are the global cases which clearly are now accelerating as china has managed to flatten its curve. if you look at the beginning of the graph you'll see where china implemented the lockdowns in wuhan and hubei province they estimated it was about 25 days from that lockdown and the quarantine until they started to see new case numbers start to slow down and they do point out

meg terrell. the white house, in the meantime, proposing stimulus to boost the economy, but we are still awaiting details about what exactly that will look like eamon javers has the latest at the white house for us eamon? >> reporter: kelly, we have just learned that the president of the united states has declared a nationwide disaster declaration is under consideration at the twho white house. i am told by a white house official that this idea was discussed with senate republicans in the congressional lunch yesterday with the president, it is actively under consideration now. the appeal for this idea, kelly, is that ultimately, it would free up billions, if not tens of billions of dollars of federal aid for areas that have been hard hit by this virus it would put fema fully in the fight here against the coronavirus. and ultimately, there are a lot of fema tasks that you think of that are covered by the federal government that wouldn't apply here, like debris removal and that sort of thing that yo

let's get more on this good news story with meg terrell meg? >> it's the kind of bombshell we're all looking forethese days, j & j accelerating its time lines for a potential vaccine. saying they have selected a lead candidate and plan to start human clinical trials in september. if all goes well, they could have a vaccine ready for emergency use authorization from the fda in early 2021. that would be just record time here we have a layout of the other players in the field mederna has already started its phase one trial. if that goes well, that vaccine could be available early to mid next year as well. take a listen to sidewaquawk bos morning. >> we expect to have interim results from our trials in december that should put us in a position early in 2021 to literally hundreds of millions of doses available and then by the end of the year, up to a billion. this is a bit of a moon shot for j & j going-forward, it's one we feel is very important for us to be doing at this point in time >> that would be record speed for vaccine development. we have

coronavirus tests, and that includes one from german's qiagen, which can deliver results in about an hour meg terrellhere with those details. meg? >> reporter: hi, kelly the german company saying it's shipping that test to the united states this week to potentially begin to be used there are a lot of good things about this test. now, it can return results in about an hour, as you said it tests not only for the coronavirus, but also 20 other viruses that cause respiratory infections, including flu and the other coronaviruses that we associate more with colds. it is installed in about 1,100 instruments around the world and hospitals, labs, and clinics, it can be run on those instruments, including about 200 in the united states. so there's a question about how widely will this be used and how much capacity will it add to the system additionally, qiagen is a major maker of the rna extraction kits that are used to run the coronavirus tests from other companies, as well so we've got a lot of questions about this, and joining us to answer those is qiagen ceo, terry bernard. terry, thank you so much for bei

let's get more of the details and this with meg terrell. meg?, brian regeneron is working on a unique approach that could be used both similarly to a vaccine and as a treatment for the infection and it provided an update for getting into human testing that's two months earlier than expected by early summer the company's approach is to develop antibodies that neutralize the virus and regeneron scientists are sorting through those as well as antibodies from people who recovered from covid-19 to find the best two for a cocktail to start human trials as they do this, they'll be scaling up capacity to produce hundreds of thousands of doses a month for preventive use by the end of the summer and this is a different approach from what we heard yesterday which is a test for rheumatoid arthritis drug k kevzara. all of these things take time and for the antibody approach regeneron will have to prove it's safe and effective before it be used more broadly, but remember, they have done this before, for ebola developing a three antibod i cocktail to save peop

meg terrell joins us where we stand, terrell, meg. >> hi, brian as we are doing the social distancingking from home to try to flatten the curb, rbc's team led by canon mckay did some modeling looking at what we can learn from china, italy and other places and we've gotten some of the graphs re-created here for you so the red line here are the total cases in china and the blue line are the global cases which clearly are now accelerating as china has managed to flatten its curve. if you look at the beginning of the graph you'll see where china implemented the lockdowns in wuhan and hubei province they estimated it was about 25 days from that lockdown and the quarantine until they started to see new case numbers start to slow down and they do point out that the lunar new year was around that time and remember, everybody was very concerned that all of the travel people were doing was going to exacerbate the spread of the disease. mckay said that may have helped because it enabled people to not be working and stay at home kind of what we're trying to do now as we look at the numbers on whe

developments coming at a cost off other drugs in the pipeline for more on that story let's bring in meg terrell meg? >> reporter: hi, is kelly. the covid-19 pandemic is disrupting all kinds of businesses including clinical trials around the world. basically every major company has said there will be some potential impact to ear ongoing clinical trials or enrolling new clinical trials and these are some companies that put out press releases saying they are seeing these potential delays or who we've been in contact with and who have said that in fact is the case. merck, pfizer, eli lilly, glaxosmithkline, galapagos which has partnered with gilad, bluebird bio and vertex pharmaceuticals which just said that this morning they might see potential delays in clinical trials or in starting new ones that company also saying though they don't expect any kind of supply disruptions to their existing mid-sins joining us to discuss that more is dr. jeff lydon, the ceo of vertex pharmaceuticals good to have you on the phone with us. talk to us about these potential delays we're seeing in clinical trials acros

have a little bit of good news on that front, as well and who else is going to deliver that than meg terrell joining us, and i know how tough it is being physical distancing, social distancing, whatever you want to call it. how hard that is for so many people in the united states and the world, but you've got some data that shows that as tough as it is, it does appear to be working on many fronts >> yes, brian, it does appear to be working and that gentleman you just showed waiting for the briefing to start, that was dr. anthony fauci and he said he is seeing glimmers of where this is working. two of those cities and counties are seattle and san francisco. this is where it appears that social distancing really is starting to flatten the curve. seattle's can count the cases at 2300 san francisco is under 400 there and those curves are looking like they're flat. in san francisco, hospitals reporting that they're seeing a leveling off of cases. in seattle two studies showing they decreased mobility and the transition of the virus to climb, as well >> here in new york governor cuomo, the state c

meg terrell is back at hq with all of the latest headlines, meg. >> case numbers are continuing to rise in the united states with an additional two deaths reported today, including the first outside of washington state in california. now, that brings the total number of deaths here to 11. l.a. county declaring a health emergency as it announced six additional cases but noted they're ought traceableto travel and they haven't yet detected community spread. >> in new york, a wilawmakers agreeing on more than $8 billion to fight the coronavirus this after vice president mike pence met with testing companies to discuss expanding the u.s.'s diagnostic capacity. >> thank you. >>> the international monetary fund laying out a coordinated response to coronavirus. the world bank out with $12 billion in aid last night. the imf joining in today, breaking with us news of a $50 billion loan package in the first on cnbc with the manager of the fund, she talked about where she wants to see the money being used. >> we would like very much to see them prioritizing first and foremo foremost beefing up the

meg terrell is here with what we know at this hour. >> u.s. case numbers are mounting now that state and local labs are gaining their own ability to run tests there are 44 cases here according to the cdc, officials closely watching an outbreak in a nursing facility, while new york also confirming its first case governor cuomo saying today, community spread is inevitable the world health organization saying, it's not yet a pandemic, noting 90% of cases have been reported in china. it will not hesitate to describe the situation as a pandemic if that's what the evidence suggests we're going to see pharmaceutical representatives at the white house for a meeting on vaccine and drug development. >> meg, we were just discussing as we pay attention to all the economic data. tomorrow's super tuesday i mean, talk about an event that's going to bring people into crowded places. i wonder if that will hurt voter turnout, it's going to be tough to tell, but it's a factor we weren't anticipating >> definitely not. and we already heard from the chicago board

. >>> let's bring in meg terrell now with more on what's going on in italy and what it could signal heren the u.s hi, meg. >> reporter: hi, ty. people are watching those italy numbers really closely and as sue just detailed, we just got their update for today. the reason people are watching them so closely is because on saturday, we saw what looked like could be a peak in the new daily case counts and the new numbers of deaths reported each day. they did start to decline after that, although they picked up again yesterday. the numbers they just reported, which sue mentioned, those 683 deaths and 52,010 new cases, that is a slight downtick from yesterday. so people hoping, does this mean italy has turned a corner? i talked with several epidemiologists and public health experts who say, it is just too soon to know. dr. mike osterhome with the university of minnesota says we need at least two weeks' more data to really get a sense of how much testing is being done, the workload there the numbers could be skewed because of how much they're able to process bill henich at harvard saying we nee

joining us with more, senior writer at stat news as well as or own meg terrell what's your take on how close we're getting if at all to some of these potential treatments provided of course they are indeed effective treatments? i don't know if we've got matthew either/or meg at the moment so we will try and get both of those up to speed but sara of course is still with me. meg is now good as well. meg joins us just the question i was putting to matthew there about these potential treatments we discussed it a bit last hour. how close are we to realistically having something that is effective and can be used >> well, we should get data in the next month in april. that's the soonest we're expected to get data on remdesivir from some clinical trials being run in china and also from some u.s. trials by regeneron on their existing rheumatoid arthritis drug. that unfortunately isn't rolling very quickly i say unfortunately because it's being used for very severe patients who are hospitalized for covid-19 the company told me today because so many people are being hospitalized at that severe le

let's get to meg terrell at hq for all the latest. >> cases now stopping 96,000 with more than 3300 deaths in the u.s. more states are reporting more cases, including new jersey bill de blasio tweeting new york city has two more cases and neither in connection to travel or other cases california declaring a state of emergency. in king county, washington, people are reporting people at high risk of more severe disease stay home and away from large crowds of people the u.s. department of health saying it plans to purchase 500 million n-95 respirator masks over the next year and a half after the u.s. told congress they have only 3.5% needed in a pandemic vaccine and drug development is continuing at a rapid clip kaiser permanente saying it's beginning a clinical trial and has started enrolling healthy seattle area adults between 18 and 55 years old guys. >> all right, meg, thank you speaking of moderna, b of a cuts it to neutral today based on the year to date performance. >> notice the words that meg picked healthy individuals. now, we know in our country the fda swears the last thing you wa

of the lows that we have seen this session but after 1,300 point advance yesterday, let's get to meg terrelle c organizatiorons update desk at cnbc. don't touch it >> so much hand washing. numbers are continuing to climb and the case is now topping 5,000. it's more than 2,300 in italy and more than 2,000. china with new case numbers declining now implementing measures in several large cities to quarentine travelers returning from those countries at least 13 people have been diagnosed after returning from iran and italy and then the u.s. has the ability to test here grows more cases being diagnosed as well. more than 100 confirmed cases in 15 states and six deaths all reported in washington state measures taken across the country to try to limit the spread of the disease. this as they met with the president to discuss time lines with vaccines and therapeutics it will be a year until a vaccine is widely available they said therapeutics may work more quickly. we'll talk more about that on the exchange >> thank you for more on the coronavirus, she is associate professor thank youing thank you fo

let's get the latest on the coronavirus outbreak we'll get over to meg terrell. >> becky, case countsore than 4,000 italy has the most cases outside of china at 9,000 and the most deaths at 463. the country extending the lockdown on the northern region to all of its 60 million citizens in an attempt to slow the virus's spread in the u.s. cases reaching 755 with 26 deaths new jersey and florida the latest states to declare emergencies. in seattle, drive through testing for covid-19 has begun at the washington medical center the testing is for staff and faculty and the results are available in one to two days this as the cdc warning of the risk of older americans and those with underlying conditions it's likely many will be exposed to the virus this year and next. the threat of a pandemic has become very real but it would be the first pandemic in history that could be controlled joe? >> interesting way of putting it, meg. thank you. for more on the fight of the coronavirus in the u.s. let's welcome michael osterholm. director of the university of minnesota center for infectious disease